Knoll Capital Management, LP Buys Corbus Pharmaceuticals Holdings Inc, Blackstone Group LP, Altria Group Inc, Sells Krystal Biotech Inc, Evoke Pharma Inc, ChromaDex Corp

• New Purchases: BX, MO, DWDP,
• Added Positions: CRBP,
• Reduced Positions: KRYS, GLMD,
• Sold Out: EVOK, CDXC,

For the details of Knoll Capital Management, LP's stock buys and sells, go to https://www.gurufocus.com/guru/knoll+capital+management%2C+lp/current-portfolio/portfolio

1. Biohaven Pharmaceutical Holding Co Ltd (BHVN) - 749,815 shares, 30.03% of the total portfolio.
2. Corbus Pharmaceuticals Holdings Inc (CRBP) - 4,985,870 shares, 26.96% of the total portfolio. Shares added by 22.72%
3. Abeona Therapeutics Inc (ABEO) - 2,359,767 shares, 13.51% of the total portfolio.
4. Krystal Biotech Inc (KRYS) - 209,986 shares, 5.38% of the total portfolio. Shares reduced by 30%
5. Blackstone Group LP (BX) - 153,000 shares, 4.16% of the total portfolio. New Position

Knoll Capital Management, LP initiated holding in Blackstone Group LP. The purchase prices were between $29.23 and $35.47, with an estimated average price of $33.31. The stock is now traded at around $39.58. The impact to a portfolio due to this purchase was 4.16%. The holding were 153,000 shares as of .

Knoll Capital Management, LP initiated holding in Altria Group Inc. The purchase prices were between $43.33 and $57.43, with an estimated average price of $51. The stock is now traded at around $52.13. The impact to a portfolio due to this purchase was 4.02%. The holding were 90,000 shares as of .

Knoll Capital Management, LP initiated holding in DowDuPont Inc. The purchase prices were between $34.76 and $39.85, with an estimated average price of $36.86. The stock is now traded at around $30.10. The impact to a portfolio due to this purchase was 2.5%. The holding were 90,000 shares as of .

Knoll Capital Management, LP added to a holding in Corbus Pharmaceuticals Holdings Inc by 22.72%. The purchase prices were between $5.76 and $8.95, with an estimated average price of $7.36. The stock is now traded at around $7.39. The impact to a portfolio due to this purchase was 4.99%. The holding were 4,985,870 shares as of .

Knoll Capital Management, LP sold out a holding in Evoke Pharma Inc. The sale prices were between $1.18 and $3.2, with an estimated average price of $2.39.

Knoll Capital Management, LP sold out a holding in ChromaDex Corp. The sale prices were between $3.2 and $4.19, with an estimated average price of $3.6.